Organization | Neurological Associates of West Los Angeles

Neurological Associates of West Los Angeles Report issue

Academic/Hospital Phase 1

Founded: Santa Monica CA United States (1981)

Organization Overview

First Clinical Trial

2016

NCT02921477

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Neurological Associates of West Los Angeles | The Neurological Associates of West Los Angeles

Active Ingredients

Drugs in Phase 1 Trials (5)

blood plasma (1 trial)

bosutinib (bosulif) (1 trial)

dexmedetomidine (precedex) (1 trial)

ketamine (ketalar) (1 trial)

plasmalogen (1 trial)

Drugs in Other Trials (3)

autologous adipose-derived mesenchymal stem cells (1 trial)

exosomes from mesenchymal stem cells (2 trials)

omega-3 fatty acids (omacor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Alzheimer Disease (Phase 1)

Cognitive Dysfunction (Phase 1)

Dementia (Phase 1)

Depression (Phase 1)

Overview

Highest Phase: Phase 1
# of Trials: 9
# of Trial APIs: 8